We speculate that under less extreme degrees of cellular disintegration, and in more physiological models, which are likely to be more reflective of early disease states in patients with ALS-FTD, Sarm1 deletion may have a greater ability to attenuate behavioural and motor dysfunction. Here, SARM1 is linked to amyotrophic lateral sclerosis.